PL2163247T3 - Zastosowanie naringeniny i naringiny jako inhibitorów dla ścieżki sygnałowej transformującego czynnika wzrostu BETA1 - Google Patents
Zastosowanie naringeniny i naringiny jako inhibitorów dla ścieżki sygnałowej transformującego czynnika wzrostu BETA1Info
- Publication number
- PL2163247T3 PL2163247T3 PL08772950T PL08772950T PL2163247T3 PL 2163247 T3 PL2163247 T3 PL 2163247T3 PL 08772950 T PL08772950 T PL 08772950T PL 08772950 T PL08772950 T PL 08772950T PL 2163247 T3 PL2163247 T3 PL 2163247T3
- Authority
- PL
- Poland
- Prior art keywords
- naringin
- naringenin
- inhibitors
- growth factor
- signaling pathway
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101188713A CN101322700B (zh) | 2007-06-13 | 2007-06-13 | 柚皮素和柚皮苷作为转化生长因子-β1信号通路抑制剂在制备药物中的应用 |
EP08772950.5A EP2163247B1 (en) | 2007-06-13 | 2008-06-11 | USE OF NARINGENIN AND NARINGIN AS INHIBITORS FOR TRANSFORMING GROWTH FACTOR-beta1 SIGNALING PATHWAY |
PCT/CN2008/001129 WO2008151519A1 (fr) | 2007-06-13 | 2008-06-11 | UTILISATION DE NARINGÉNINE ET DE NARINGINE EN TANT QU'INHIBITEURS POUR LA TRANSFORMATION D'UNE VOIE DE SIGNALISATION DU FACTEUR DE CROISSANCE β1 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2163247T3 true PL2163247T3 (pl) | 2015-02-27 |
Family
ID=40129230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08772950T PL2163247T3 (pl) | 2007-06-13 | 2008-06-11 | Zastosowanie naringeniny i naringiny jako inhibitorów dla ścieżki sygnałowej transformującego czynnika wzrostu BETA1 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2163247B1 (pl) |
JP (1) | JP5484320B2 (pl) |
CN (1) | CN101322700B (pl) |
DK (1) | DK2163247T3 (pl) |
ES (1) | ES2519040T3 (pl) |
PL (1) | PL2163247T3 (pl) |
WO (1) | WO2008151519A1 (pl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102302483A (zh) * | 2011-07-08 | 2012-01-04 | 中国科学院生物物理研究所 | 黄酮类小分子药物在抗炎及相关疾病中的应用 |
WO2014063660A1 (en) * | 2012-10-26 | 2014-05-01 | The Chinese University Of Hong Kong | Naringenin and asiatic acid combination treatment of fibrosis |
JP2016027015A (ja) * | 2014-06-24 | 2016-02-18 | 花王株式会社 | Smad3阻害剤 |
CN113521056A (zh) | 2015-07-10 | 2021-10-22 | 中国科学院生物物理研究所 | 柚皮素和柚皮苷在肿瘤放射治疗中的应用 |
US20180228815A1 (en) * | 2016-11-09 | 2018-08-16 | The Chinese University Of Hong Kong | Naringenin and asiatic acid combination treatment of cancers |
CN106880685B (zh) * | 2017-02-21 | 2020-07-17 | 新乡医学院第一附属医院 | 一种治疗肝纤维化的复方制剂及其制备方法 |
WO2019200585A1 (en) * | 2018-04-19 | 2019-10-24 | The Chinese University Of Hong Kong | Naringenin and asiatic acid combination treatment of cancers |
CN109771412A (zh) * | 2018-12-29 | 2019-05-21 | 遵义医学院 | 减轻球囊损伤后血管再狭窄的药物及大鼠模型构建方法 |
US20230172901A1 (en) * | 2020-05-08 | 2023-06-08 | Gretals Australia Pty Ltd | Compositions and methods for the prophylaxis and treatment of fibrotic and inflammatory conditions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2633182B1 (fr) * | 1988-06-23 | 1993-07-23 | Beljanski Mirko | Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention |
US6239114B1 (en) * | 1997-09-26 | 2001-05-29 | Kgk Synergize | Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols |
US20040087527A1 (en) * | 2002-10-31 | 2004-05-06 | Day Brian J. | Methods for treatment of thiol-containing compound deficient conditions |
US20080200538A1 (en) * | 2005-05-26 | 2008-08-21 | The Ohio State University Research Foundation | Inhibition of Monocyte Survival, Differentiation, or Proliferation |
CN1813779A (zh) * | 2005-11-23 | 2006-08-09 | 中山大学 | 柚皮苷在制备防治流感药物中的应用 |
-
2007
- 2007-06-13 CN CN2007101188713A patent/CN101322700B/zh active Active
-
2008
- 2008-06-11 PL PL08772950T patent/PL2163247T3/pl unknown
- 2008-06-11 ES ES08772950.5T patent/ES2519040T3/es active Active
- 2008-06-11 DK DK08772950.5T patent/DK2163247T3/da active
- 2008-06-11 JP JP2010510637A patent/JP5484320B2/ja active Active
- 2008-06-11 WO PCT/CN2008/001129 patent/WO2008151519A1/zh active Application Filing
- 2008-06-11 EP EP08772950.5A patent/EP2163247B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2163247A1 (en) | 2010-03-17 |
WO2008151519A1 (fr) | 2008-12-18 |
JP5484320B2 (ja) | 2014-05-07 |
DK2163247T3 (da) | 2014-11-10 |
EP2163247A4 (en) | 2010-07-14 |
ES2519040T3 (es) | 2014-11-06 |
CN101322700B (zh) | 2010-08-25 |
CN101322700A (zh) | 2008-12-17 |
EP2163247B1 (en) | 2014-08-20 |
JP2010529049A (ja) | 2010-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2163247T3 (pl) | Zastosowanie naringeniny i naringiny jako inhibitorów dla ścieżki sygnałowej transformującego czynnika wzrostu BETA1 | |
HUS2200052I1 (hu) | Imidazotriazinok és imidazopirimidinek mint kinázgátlók | |
HK1254895A1 (zh) | 苄基苯衍生物及使用方法 | |
IL211549A0 (en) | Aminotriazolopyridines and their use as kinase inhibitors | |
HK1162352A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof -3- | |
EP2311002A4 (en) | SYSTEMS AND METHOD FOR THE VISUAL PRESENTATION OF OFFERS | |
EP2114983A4 (en) | TYROSINE KINASE ACTIVATED AXL RECEPTOR INHIBITORS AND METHODS OF MAKING AND USING THE SAME | |
ZA200905626B (en) | Adjuvants and methods of using them | |
EP2046374A4 (en) | COMPOSITIONS AND METHODS FOR GROWTH INHIBITION OF SMAD4-DEFICIENT TUMORS | |
EP2376014A4 (en) | OBERKIEFERKNOCHEN CUTTING AND INJECTION SYSTEM AND USE METHOD THEREFOR | |
IL212755A0 (en) | Pyrazinopyrazines and derivatives as kinase inhibitors | |
EP2451376A4 (en) | METHOD AND SYSTEMS FOR ADJUSTING THE PH VALUE OF MEDICAL BUFFER SOLUTIONS | |
ZA200907337B (en) | Methods of increasing plant growth | |
AP2008004406A0 (en) | Methods of managing timberland | |
IL200387A0 (en) | Heterocylic compounds, compositions comprising them and methods of their use | |
ZA200808245B (en) | Compositions and methods for inducing bone growth and inhibiting bone loss | |
EP2459187A4 (en) | COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH | |
ZA201102547B (en) | Compositions and methods for the rapid growth and detection of microorganisms | |
IL205821A0 (en) | Method and compositions for cutaneous immunisation | |
AP2784A (en) | Methods of managing timberland | |
EP2252939A4 (en) | METHOD AND SYSTEMS FOR SYNCHRONIZING MULTIPLE APPLICATIONS | |
WO2008153938A3 (en) | Epigallocatechin-3-gallate crystal compositions | |
EP1999248A4 (en) | DEVICES AND METHODS FOR ISOLATION AND CULTURE OF MICROORGANISMS | |
EP2280698A4 (en) | PROCESS FOR INHIBITING BACTERIAL GROWTH | |
GB2449891B (en) | Drinking device and method of drinking |